Compare Uniphos Enter. with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.83
- The company has reported losses. Due to this company has reported negative ROCE
Flat results in Dec 25
Risky - Negative EBITDA
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Aug-29-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Uniphos Enterprises Ltd Technical Momentum Shifts Amid Mixed Market Signals
Uniphos Enterprises Ltd has experienced a notable shift in price momentum, reflected in a complex blend of technical indicator signals. Despite a recent 4.97% rise in the stock price to ₹105.60, the overall technical outlook remains cautiously bearish, with key indicators such as MACD and moving averages signalling mild weakness. This nuanced scenario presents a challenging environment for investors seeking clarity on the stock’s near-term trajectory.
Read full news article
Uniphos Enterprises Ltd is Rated Strong Sell
Uniphos Enterprises Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 April 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Uniphos Enterprises Ltd is Rated Strong Sell
Uniphos Enterprises Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 September 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 30 March 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article Announcements 
Closure of Trading Window
31-Mar-2026 | Source : BSEPlease find attached Intimation of Closure of Trading Window
Announcement under Regulation 30 (LODR)-Newspaper Publication
07-Feb-2026 | Source : BSEPlease find attached copy of newspaper publication of an extract of Unaudited Financial Results for the quarter and nine months ended 31st December 2025.
Board Meeting Outcome for UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 2025
06-Feb-2026 | Source : BSEPlease find attached Unaudited Financial Results for the quarter and nine months ended 31st December 2025.
Corporate Actions 
No Upcoming Board Meetings
Uniphos Enterprises Ltd has declared 25% dividend, ex-date: 29 Aug 25
No Splits history available
No Bonus history available
Uniphos Enterprises Ltd has announced 173:100 rights issue, ex-date: 18 Sep 13
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 3 Schemes (0.0%)
Held by 14 FIIs (15.71%)
Nerka Chemicals Pvt Ltd (73.28%)
Ares Diversified (4.56%)
8.94%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -104.36% vs 3,229.73% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -82.51% vs 0.00% in Sep 2024
Growth in half year ended Sep 2025 is 504.31% vs -90.55% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -84.82% vs 0.00% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 1,057.30% vs -95.29% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 120.16% vs 3,345.58% in Mar 2024
YoY Growth in year ended Mar 2025 is -99.27% vs -1.58% in Mar 2024






